Experimental Physiology
	

Celebrating 100 years
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Physiology in Press

First published online on December 16, 2004.
Experimental Physiology (2004)
DOI: 10.1113/expphysiol.2004.029058
© The Physiological Society 2004

A more recent version of this article appeared on March 1, 2005
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
90/2/175    most recent
expphysiol.2004.029058v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jordan, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jordan, D.

Received October 18, 2004
Revised November 15, 2004
Accepted after revision November 23, 2004


Cardiovascular control

Vagal Control of the Heart: Central serotonergic (5-HT) mechanisms

David Jordan 1*

1 Royal Free & University College Medical School

* To whom correspondence should be addressed. E-mail: d.jordan{at}rfc.ucl.ac.uk.


   Abstract
Cardiac vagal preganglionic neurones (CVPNs) are located within the dorsal vagal nucleus (DVN) and the nucleus ambiguus (nA). In mammals, nA vagal preganglionic neurones have small myelinated axons and mediate major chronotropic effects, those in DVN having non-myelinated axons and mediating smaller chronotropic, dromotropic and inotropic effects. Numerous studies demonstrate important influences of serotonin (5-HT) at multiple sites controlling autonomic outflows including nucleus tractus solitarius (NTS) where cardiorespiratory afferent fibres terminate, the CVPNs and rostral ventrolateral medulla (RVLM) - location of sympathetic premotor neurones. We have demonstrated roles for some of the numerous 5-HT receptor subtypes (5-HT1, 5-HT2, 5- HT3, 5-HT4 and 5-HT7) in brainstem regions involved in cardiac control. Intracisternal application (i.c.) of selective ligands was used to study the effect of 5-HT receptors on heart rate and its reflex control. Further electrophysiological studies were also carried out to delineate their location and mechanisms of action of these ligands. Blocking 5-HT1A receptors attenuated bradycardias evoked by stimulating baroreceptor and cardiopulmonary afferents but not arterial chemoreceptors whereas antagonising 5- HT7 receptors markedly attenuated all these reflex bradycardias. Within the DVN, nA and NTS activation of 5-HT1A receptors could excite or inhibit neurones. In NTS 5-HT2 receptors also had variable effects, 5-HT2B receptors excite and 5-HT2C receptors inhibit. Antagonism of 5-HT3 receptors attenuated upper airway and cardiopulmonary reflex bradycardias - compatible with data showing that 5-HT3 receptors excite DVN and NTS neurones by a glutamate dependent mechanism. The origin of the glutamate (neuronal or glial) remains unresolved but glia are a possibility since baro-sensitive NTS neurones receive few direct 5-HT containing synaptic contacts. Thus, 5-HT plays a critical role in the control of vagal outflow to the heart, however, why so many different receptors are involved, and their relative functional roles remains unresolved.

Key Words: 5-Hydroxytryptamine, Heart, Vagus







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2004 by the The Physiological Society.